BD Expands from Cancer Discovery and Diagnosis into Post …
https://news.bd.com/2022-02-01-BD-Expands-from-Cancer-Discovery-and-Diagnosis-into-Post-Treatment-Monitoring-with-Acquisition-of-Cytognos-from-Vitro-S-A
WEBFeb 1, 2022 · Cytognos' key products increase BD's comprehensive portfolio of diagnostic and research solutions for certain types of cancers that use flow cytometry as the primary means of discovery, diagnosis and understanding, including lymphoma, leukemia and multiple myeloma.
DA: 65 PA: 63 MOZ Rank: 47 Up or Down: Up